U.P. Oncolytics has secured an economic development grant to advance its groundbreaking therapy for brain cancer—a milestone that brings hope to patients and honors Lake County’s thriving life science ecosystem. U.P. Oncolytics has leveraged its location at Rosalind Franklin University’s Helix 51 incubator to foster early-stage breakthroughs with state-of-the-art wet labs, clean rooms, and specialized resources. This cutting-edge environment attracts and nurtures firms like U.P. Oncolytics, Artec Biotech, BLR Bio, and others, to drive novel treatments for brain cancer, fibrotic diseases, immune disorders and more.
< BACK TO MAIN NEWS PAGE